Glen Eagle Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-180
| Closed | -$20.1K | – | 970 |
|
|
2021
Q3 | $20.1K | Hold |
180
| – | – | 0.01% | 557 |
|
|
2021
Q2 | $29.1K | Hold |
180
| – | – | 0.01% | 475 |
|
|
2021
Q1 | $21.9K | Hold |
180
| – | – | 0.01% | 505 |
|
|
2020
Q4 | $27.6K | Hold |
180
| – | – | 0.01% | 434 |
|
|
2020
Q3 | $15.1K | Hold |
180
| – | – | 0.01% | 514 |
|
|
2020
Q2 | $13.2K | Hold |
180
| – | – | 0.01% | 514 |
|
|
2020
Q1 | $7.63K | Buy |
180
+70
| +64% | +$2.97K | 0.01% | 560 |
|
|
2019
Q4 | $6.7K | Buy |
+110
| New | +$6.7K | ﹤0.01% | 667 |
|